COVID-19 : ADO Guidance For Resuming Testing / World Anti-Doping Agency (WADA). - Montreal : WADA, 2020
Following on from its COVID-19 guidance of 20 March, the World Anti-Doping Agency (WADA) has issued updated guidance for Anti-Doping Organizations (ADOs) focused on the resumption of athlete testing as deconfinement leads to the restart or return to normal of doping control programs in a number of countries around the world.
WADA developed the guidance following consultation with a group of National Anti-Doping Organizations (NADOs) to determine how the anti-doping community can best operate their testing programs in this challenging environment. The guidance follows globally recommended health and hygiene procedures and is in line with the International Standard for Testing and Investigations.
The guidance has been refined to reflect the evolving nature of the pandemic, its effect on the global testing program and the fact that some parts of the world that had suspended or significantly reduced testing are getting back to normal as restrictions begin to be lifted. It covers a number of areas, concentrating in particular on what procedures should be employed by ADOs and their sample collection personnel when conducting testing during this period.
This document includes:
1.) Guidance on the actions or the steps that ADOs should consider, and who they should communicate with (e.g., Sample Collection Authorities – SCAs) as they prepare to resume testing activities;
2.) Examples of measures that should be added to sample collection procedures (Annex A) as well as an example of a ‘COVID-19 Athlete Questionnaire’ (Annex C); and
3.) Supporting information and best practices regarding the use of personal protective equipment (PPE) (Annex B).
